Product Name: Human Kallikrein Antibody (Lanadelumab, Research Use)
Catalog Number: NBR-0320
Target Name: Kallikrein
Trade Name: Lanadelumab
Antibody Drug Description: Lanadelumab (INN; trade name Takhzyro) is a human monoclonal antibody (class IgG1 kappa) that targets plasma kallikrein (pKal)[6] in order to promote prevention of angioedema in patients with hereditary angioedema. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: Kallikrein
Synonyms: Klk6
Target Description: Serine protease which exhibits a preference for Arg over Lys in the substrate P1 position and for Ser or Pro in the P2 position. Shows activity against amyloid precursor protein, myelin basic protein, gelatin, casein and extracellular matrix proteins such as fibronectin, laminin, vitronectin and collagen. 
Ensembl: ENSG00000167748
Uniprot: P06870